Balyasny Asset Management’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
Other funds holding PLSE
Balyasny Asset Management's PLSE Position: Q3 2026 in Review
Balyasny Asset Management reduced its Pulse Biosciences (PLSE) stake by 12% in Q3 2026, selling an estimated $3.65M and leaving 631,669 shares worth $31.5M. The position accounts for 0.04% of the portfolio, ranked #570.
Balyasny Asset Management first reported a position in PLSE in Q1 2026 and has held it in 3 quarters since. 142 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.
- Balyasny Asset Management held 631,669 shares of Pulse Biosciences worth $31.5M as of Q3 2026.
- Balyasny Asset Management sold 86,434 Pulse Biosciences shares in Q3 2026, an estimated $3.65M.
- Pulse Biosciences made up 0.04% of Balyasny Asset Management's portfolio in Q3 2026, its #570 holding.
- Balyasny Asset Management first reported a position in Pulse Biosciences in Q1 2026 and has held it in 3 quarters since.
- 142 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.